Fundz

Georgiamune reported raising $92.7 Million in an initial SEC Form D filing, from an offering of $132 Million

PRIVATEAug 17, 2026

Amount Raised

$92.7 Million

$92.7 Million sold, per SEC Form D (first sale Jul 16, 2026)

Round Type

Venture

GaithersburgBiotechnologyHealth CareMedicalTherapeutics

Investors

Catalio Capital ManagementAlexandria Venture InvestmentsMubadala Capital

Who to call at Georgiamune, and when

A new round usually means Georgiamune is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Georgiamune raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Georgiamune, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Georgiamune

Location

Gaithersburg, Maryland, United States

About

Georgiamune Inc. is a clinical-stage science and discovery biotechnology company focused on reprogramming immune signaling pathways to redirect the immune system to fight diseases. Georgiamune has designed unique approaches to re-establish immune balance, and its scientific discoveries have led to pioneering immunotherapies targeting high unmet needs. The company's lead program, GIM-122, is a first-in-class, dual-functioning monoclonal antibody. GIM-122 is designed to overcome immune therapy resistance in cancer patients. In addition to its lead program, the company is advancing a pipeline of first-in-class therapies for cancer and autoimmune diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Georgiamune raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Georgiamune's next move

See what Strategic adds

Georgiamune raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.